Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Pharma AidsDHA:PHARMAID -2.55%73 Net Margin % is 15.48% as of Mar. 2026, which is 3% below its 10-year median of 15.92. GuruFocus rates DHA:PHARMAID with a GF Score™ of 73/100 and a GF Value™ of BDT758.56 (Modestly Undervalued). The stock has 3 warning signs investors should review. Among 817 Medical Devices & Instruments companies, Pharma Aids ranks better than 82.99% on this metric.
Net margin is calculated as Net Income divided by its Revenue. Pharma Aids's Net Income for the
three
months ended in Mar. 2026 was BDT19.1 Mil. Pharma Aids's Revenue for the
three
months ended in Mar. 2026 was BDT123.3 Mil. Therefore, Pharma Aids's net margin for the quarter that ended in Mar. 2026 was 15.48%.
The historical rank and industry rank for Pharma Aids's Net Margin % or its related term are showing as below:
DHA:PHARMAID'
s Net Margin % Range Over the Past 10 Years
Min: -2.07 Med: 15.92 Max: 20
Current: 15.66
DHA:PHARMAID's Net Margin % is ranked better than 82.99% of 817
companies
in the Medical Devices & Instruments industry
Industry Median: 2.07
vs DHA:PHARMAID: 15.66
Pharma Aids (DHA:PHARMAID) Net Margin % Explanation
Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.
But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.
Pharma Aids Net Margin % Related Terms
Pharma Aids Net Margin % Historical Data
* Premium members only.
The historical data trend for Pharma Aids's Net Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
DHA:PHARMAID vs ISRG, BDX, MDLN: Net Margin % Comparison
For the Medical Instruments & Supplies subindustry, Pharma Aids's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Pharma Aids Net Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Pharma Aids's Net Margin % distribution charts can be found below:
* The bar in red indicates where Pharma Aids's Net Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Pharma Aids (DHA:PHARMAID) has a Net Margin % of 15.48% as of Mar. 2026. Net margin is the ratio of total net income to net sales. View historical data on Pharma Aids and its competitors. This is near median its historical median of 15.92. According to the industry distribution chart, Pharma Aids ranks #139 out of 817 companies in the Medical Devices & Instruments industry, placing it in the top 17%.
Is Pharma Aids' Net Margin % too high?
Pharma Aids' current Net Margin % of 15.48% is near median its 10-year median of 15.92. The Medical Devices & Instruments industry median Net Margin % is 2.07. Pharma Aids' value of 15.48% is 647.8% above this industry median. Based on the distribution chart, Pharma Aids ranks #139 out of 817 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Pharma Aids has a GF Score™ of 73/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Pharma Aids' Net Margin % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Pharma Aids ranks #139 out of 817 companies for Net Margin %. This places Pharma Aids in the top 17% of its industry — outperforming the majority of peers. The industry median Net Margin % is 2.07. Pharma Aids' value of 15.48% is 647.8% above this benchmark. While the company's 10-year median is 15.92 vs. the industry median of 2.07, Pharma Aids has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Medical Devices & Instruments company?
The median Net Margin % among Medical Devices & Instruments companies is 2.07, based on 817 companies in the industry. Companies in the top quartile (top 25%) have a Net Margin % significantly above this median, while those in the bottom quartile fall well below. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Pharma Aids's current Net Margin % of 15.48% is 647.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on Pharma Aids and its competitors. For the Medical Devices & Instruments industry, the median Net Margin % is 2.07 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Pharma Aids's current Net Margin % is 15.48%, which is near median its own 10-year median of 15.92. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pharma Aids stock overvalued right now?
Based on GuruFocus' analysis, Pharma Aids (DHA:PHARMAID) is currently considered Modestly Undervalued. The stock's GF Value™ is BDT758.56, compared to a current price of BDT644.70 — trading 15% below its estimated fair value. The current Net Margin % is 15.48%, which is near median its 10-year median of 15.92 and 647.8% above the Medical Devices & Instruments industry median of 2.07. Pharma Aids' overall GF Score™ is 73/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For Pharma Aids (DHA:PHARMAID), the current Net Margin % is 15.48% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Pharma Aids (DHA:PHARMAID) Overvalued in 2026?
Based on GuruFocus' analysis, Pharma Aids stock appears to be undervalued.
The current stock price of BDT644.70 is trading 15% below its estimated GF Value™ of BDT758.56.
GuruFocus considers Pharma Aids to be Modestly Undervalued.
Key valuation signals for DHA:PHARMAID:
Net Margin %: 15.48% (near median its 10-year median of 15.92)
GF Value™: BDT758.56 vs. price of BDT644.70 (15% below fair value)
Industry Position: 647.8% above the Medical Devices & Instruments median (#139 of 817)
No single metric tells the full story. See the DHA:PHARMAID stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Pharma Aids Ltd is a Bangladesh-based company engaged in the manufacturing of neutral glass ampoules, USP Type-I. Ampoules are used by pharmaceutical companies for filling liquid injections. The company produces different sizes of ampoules from 1ml to 25ml, in Clear and Amber color, and in Amber color, and of both Open Mouth (Form B and C) and Close Mouth (Form D, Din and Marzocchi type).
73GF Score
Get the complete analysis for DHA:PHARMAID
Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
DHA:PHARMAID has been successfully added to your 
